Journal Information
Original article
Prediction of clinical events by liver stiffness and chronic kidney disease by NAFLD in patients with type-2 diabetes
Predicción de eventos clínicos por elasticidad hepática y enfermedad renal crónica por EHMet en pacientes con diabetes tipo 2
Jesús Rivera-Estebana,b,
, Mònica Ponsa,b,c,1, Alejandra Planasd,e, Ramiro Manzano-Nuñeza, Cristina Hernándezb,d,e, Olga Simó-Servatd,e, Jordi Bañerasf,g, María José Solerh,i, Daniel Seronh,i, Anna Boixaderaj, Salvador Augustina,b,c,k, Rafael Simób,d,e, Ignacio Ferreira-Gonzálezb,f,g, Joan Genescàa,b,c,
, Juan M. Pericàsa,b,c, on behalf of the PRECISED consortium 2
Corresponding author
Corresponding author
a Liver Unit, Vall d’Hebron Hospital Universitari, Vall d’Hebron Institut of Research (VHIR), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
b Universitat Autònoma de Barcelona, Bellaterra, Spain
c CIBEREHD, ISCIII, Madrid, Spain
d Diabetes and Metabolism Research Unit, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Hospital Universitari, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
e CIBERDEM, ISCIII, Madrid, Spain
f Cardiology Department, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Hospital Universitari, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
g CIBERESP, ISCIII, Madrid, Spain
h Nephrology Department, Vall d’Hebron Research Institute, Vall d’Hebron Hospital, Barcelona, Spain
i REDinREN, ISCIII, Madrid, Spain
j Ophthalmology Department, Vall d’Hebron Research Institute, Vall d’Hebron Hospital, Autonomous University of Barcelona, Barcelona, Spain
k Therapeutic Area Cardio-Metabolism and Respiratory Medicine, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany
Ver más